AIHTA - Publications - Search - Cemiplimab (Libtayo®) as monotherapy for the treatment of recurrent or metastatic cervical cancer

Rothschedl, E. and Wolf, S. (2022): Cemiplimab (Libtayo®) as monotherapy for the treatment of recurrent or metastatic cervical cancer. Oncology Fact Sheet Nr. 113.

[thumbnail of Oncology Fact Sheet Nr.113.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
125kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WP Gynaecology > WP 470-480 Cervix uteri. Cervix diseases
Language:English
Series Name:Oncology Fact Sheet Nr. 113
Deposited on:03 Nov 2022 16:24
Last Modified:03 Nov 2022 16:24

Repository Staff Only: item control page